412 related articles for article (PubMed ID: 16371582)
21. Dual-energy CT for characterization of the incidental adrenal mass: preliminary observations.
Gnannt R; Fischer M; Goetti R; Karlo C; Leschka S; Alkadhi H
AJR Am J Roentgenol; 2012 Jan; 198(1):138-44. PubMed ID: 22194489
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of Malignant and Benign Adrenal Lesions With Delayed CT: Multivariate Analysis and Predictive Models.
Ng CS; Wei W; Altinmakas E; Li X; Ghosh P; Perrier NA; Grubbs E; Prieto VG; Lee JE; Hobbs BP
AJR Am J Roentgenol; 2018 Apr; 210(4):W156-W163. PubMed ID: 29412015
[TBL] [Abstract][Full Text] [Related]
23. Characterization of adrenal nodules with dual-energy CT: can virtual unenhanced attenuation values replace true unenhanced attenuation values?
Ho LM; Marin D; Neville AM; Barnhart HX; Gupta RT; Paulson EK; Boll DT
AJR Am J Roentgenol; 2012 Apr; 198(4):840-5. PubMed ID: 22451549
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of high lipid content from low lipid content adrenal lesions using single-source rapid kilovolt (peak)-switching dual-energy multidetector CT.
Morgan DE; Weber AC; Lockhart ME; Weber TM; Fineberg NS; Berland LL
J Comput Assist Tomogr; 2013; 37(6):937-43. PubMed ID: 24270116
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic performance of hepatic CT and chemical-shift MRI to discriminate lipid-poor adrenal adenomas from hepatocellular carcinoma metastases.
Nagayama Y; Hayashi H; Taguchi N; Yoshida R; Harai R; Kidoh M; Oda S; Nakaura T; Hirai T
Abdom Radiol (NY); 2024 May; 49(5):1626-1637. PubMed ID: 38456897
[TBL] [Abstract][Full Text] [Related]
26. A 10-minute CT protocol for differentiating benign from malignant adrenal masses.
Fogel J
Radiology; 2007 Mar; 242(3):947-8; author reply 948. PubMed ID: 17325079
[No Abstract] [Full Text] [Related]
27. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT.
Peña CS; Boland GW; Hahn PF; Lee MJ; Mueller PR
Radiology; 2000 Dec; 217(3):798-802. PubMed ID: 11110946
[TBL] [Abstract][Full Text] [Related]
28. Adrenal lesions: attenuation measurement differences between CT scanners.
Hahn PF; Blake MA; Boland GW
Radiology; 2006 Aug; 240(2):458-63. PubMed ID: 16801368
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.
Korobkin M; Brodeur FJ; Yutzy GG; Francis IR; Quint LE; Dunnick NR; Kazerooni EA
AJR Am J Roentgenol; 1996 Mar; 166(3):531-6. PubMed ID: 8623622
[TBL] [Abstract][Full Text] [Related]
30. Adrenal Adenoma and Pheochromocytoma: Comparison of Multidetector CT Venous Enhancement Levels and Washout Characteristics.
Northcutt BG; Trakhtenbroit MA; Gomez EN; Fishman EK; Johnson PT
J Comput Assist Tomogr; 2016; 40(2):194-200. PubMed ID: 26978001
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients.
Plaza MJ; Collado-Mesa F; Bokhoor J; Alperin N; Yepes MM
Breast J; 2014; 20(3):235-42. PubMed ID: 24750508
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.
Park SH; Kim MJ; Kim JH; Lim JS; Kim KW
Korean J Radiol; 2007; 8(4):328-35. PubMed ID: 17673844
[TBL] [Abstract][Full Text] [Related]
33. Solitary pulmonary nodule: characterization with combined wash-in and washout features at dynamic multi-detector row CT.
Jeong YJ; Lee KS; Jeong SY; Chung MJ; Shim SS; Kim H; Kwon OJ; Kim S
Radiology; 2005 Nov; 237(2):675-83. PubMed ID: 16244276
[TBL] [Abstract][Full Text] [Related]
34. CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma.
Canu L; Van Hemert JAW; Kerstens MN; Hartman RP; Khanna A; Kraljevic I; Kastelan D; Badiu C; Ambroziak U; Tabarin A; Haissaguerre M; Buitenwerf E; Visser A; Mannelli M; Arlt W; Chortis V; Bourdeau I; Gagnon N; Buchy M; Borson-Chazot F; Deutschbein T; Fassnacht M; Hubalewska-Dydejczyk A; Motyka M; Rzepka E; Casey RT; Challis BG; Quinkler M; Vroonen L; Spyroglou A; Beuschlein F; Lamas C; Young WF; Bancos I; Timmers HJLM
J Clin Endocrinol Metab; 2019 Feb; 104(2):312-318. PubMed ID: 30383267
[TBL] [Abstract][Full Text] [Related]
35. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT.
Caoili EM; Korobkin M; Francis IR; Cohan RH; Platt JF; Dunnick NR; Raghupathi KI
Radiology; 2002 Mar; 222(3):629-33. PubMed ID: 11867777
[TBL] [Abstract][Full Text] [Related]
36. Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma?
Patel J; Davenport MS; Cohan RH; Caoili EM
AJR Am J Roentgenol; 2013 Jul; 201(1):122-7. PubMed ID: 23789665
[TBL] [Abstract][Full Text] [Related]
37. Adrenal masses: CT characterization with histogram analysis method.
Bae KT; Fuangtharnthip P; Prasad SR; Joe BN; Heiken JP
Radiology; 2003 Sep; 228(3):735-42. PubMed ID: 12954893
[TBL] [Abstract][Full Text] [Related]
38. Characterization of adrenal lesions using MDCT wash-out parameters: diagnostic accuracy of several combinations of intermediate and delayed phases.
Foti G; Malleo G; Faccioli N; Guerriero A; Furlani L; Carbognin G
Radiol Med; 2018 Nov; 123(11):833-840. PubMed ID: 29923085
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic accuracy of computed tomography to identify adenomas among adrenal incidentalomas in an endocrinological population.
Marty M; Gaye D; Perez P; Auder C; Nunes ML; Ferriere A; Haissaguerre M; Tabarin A
Eur J Endocrinol; 2018 May; 178(5):439-446. PubMed ID: 29467231
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
Dong Y; Liu Q
J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
